AN, V., N, S., S, B., P, G., UE, L., D, I., & S, E. (2017). Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13). Dove Medical Press.
Cita Chicago Style (17a ed.)AN, Vasilescu, Schweinfurth N, Borgwardt S, Gass P, Lang UE, Inta D, y Eckart S. Modulation of the Activity of N-methyl-D-aspartate Receptors as a Novel Treatment Option for Depression: Current Clinical Evidence and Therapeutic Potential of Rapastinel (GLYX-13). Dove Medical Press, 2017.
Cita MLA (8a ed.)AN, Vasilescu, et al. Modulation of the Activity of N-methyl-D-aspartate Receptors as a Novel Treatment Option for Depression: Current Clinical Evidence and Therapeutic Potential of Rapastinel (GLYX-13). Dove Medical Press, 2017.